Marco Donia

14.1k citations

195 papers · 6.7k indexed · 1 hit paper · h-index 45

Impact in

Immunology top 0.5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune cells in cancer
Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research

Papers in

Immunology 125
- Immunotherapy and Immune Responses 100
- Immune Cell Function and Interaction 37
- T-cell and B-cell Immunology 14
Oncology 153
- Cancer Immunotherapy and Biomarkers 105
- CAR-T cell therapy research 98
- Cutaneous Melanoma Detection and Management 13

Co-authors: Inge Marie Svane Per thor Straten Rikke Andersen Sine Reker Hadrup Özcan Met Mads Hald Andersen Eva Ellebæk Ferdinando Nicoletti
Journals: Annals of Oncology (19 papers)Journal for ImmunoTherapy of Cancer (13 papers)European Journal of Cancer (11 papers)OncoImmunology (10 papers)Cancers (9 papers)
Partner nations: Denmark Italy United States

In The Last Decade

Marco Donia

184 papers receiving 6.6k citations

Hit Papers

align trajectories log scale

Collagen density regulates the activity of tumor-infiltrating T cells 2019 · 308 citations

Peers

Countries citing papers authored by Marco Donia

Since Specialization

Citations

This map shows the geographic impact of Marco Donia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Donia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Donia more than expected).

Fields of papers citing papers by Marco Donia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Donia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Donia. The network helps show where Marco Donia may publish in the future.

Co-authors

The 25 scholars most cited alongside Marco Donia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marco Donia Line = papers co-authored together Marco Donia links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Steroid-refractory severe immune-related mucositis following adjuvant anti-PD-1 therapy for resectable melanoma: a case report Melanoma Research ·Keshawanand Singh, Troels Holz Borch, Inge Marie Svane, Marco Donia, Eva Ellebæk	2025	0
2	The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee Journal for ImmunoTherapy of Cancer ·George Coukos, Marco Donia, Brian Gastman, Stephanie L. Goff, Alena Gros, Alexandre Harari, Nayara Toscano de Brito Pereira, Fumito Ito, Ajay V. Maker, John E. Mullinax, 正敬板野, Sara I. Pai, Sangeetha Prabhakaran, (unknown), Natalie L. Silver, Paula Marincola Smith, Simon Turcotte, 赫晓燕, James C. Yang, Michael T. Lotze	2025	0
3	The antitumor activity of TGFβ-specific T cells is dependent on IL-6 signaling Cellular and Molecular Immunology ·Sara A. Levy, 雨谷俊彦, 민덕홍, Behire Esra Çayhan, Shawez Khan, Majken Siersbæk, Fabio Vásquez López, F. V. Kusmartsev, Julie Westerlin Kjeldsen, Inge Marie Svane, Morten Bagge Hansen, Marco Donia, Julia S. Johansen, Lars Rønn Olsen, Lars Grøntved, Inna M. Chen, Luís Arnes, Morten Orebo Holmström, Mads Hald Andersen	2024	5
4	Impact of Metastatic Pattern on Survival in Patients with Posterior Uveal Melanoma: A Retrospective Cohort Study Cancers ·Lawton Deb S., Maria Alzira Ribeiro Alves COELHO, L. O. Guz, Sautso Wachepa, Listriyanto Listriyanto, Eric von Benzon, Carsten Faber, Steen F. Urbak, Marco Donia, Inge Marie Svane, Eva Ellebæk, Steffen Heegaard, Karine Madsen, Jens Folke Kiilgaard	2024	5
5	Final results: Dose escalation study of a personalized peptide-based neoantigen vaccine in patients with metastatic melanoma. Journal of Clinical Oncology ·Тоом Андрей Леонович, А М Ранчин, Onn Ben‐David, Arianna Draghi, Erika Flores Zamora, Joachim Stoltenborg Granhøj, Shang Hai Du, Im-Suck Ko, Ю. А. Болелова, Christina W. Yde, Nis Nørgaard, Torben Lorentzen, نعيمة أبو مصطفى, Anders Jespersen, Dennis Christensen, Jens Vindahl Kringelum, Marco Donia, Sine Reker Hadrup, Inge Marie Svane	2023	3
6	TIL Therapy: Facts and Hopes Clinical Cancer Research ·Guillermo Lúquez, Troels Holz Borch, Inge Marie Svane, Marco Donia	2023	62
7	Uncoupling CD4+ TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma Clinical Cancer Research ·Arianna Draghi, В.А. Алексеенко, 汪金友, Christopher A. Chamberlain, Onn Ben‐David, Trevor Brooks Langston, Mads Hald Andersen, Michael D. Crowther, Inge Marie Svane, Marco Donia	2023	11
8	Sustained improved survival of patients with metastatic melanoma after the introduction of anti-PD-1-based therapies European Journal of Cancer ·Jun Long Liao, Keshawanand Singh, E. Torrademé, Pradeep Kumar Shetty, Jasmina Panovska, Charlotte Aaquist Haslund, Henrik Schmidt, Lars Bastholt, Inge Marie Svane, Eva Ellebæk, Marco Donia	2023	6
9	1156P Immune-related adverse events in a nationwide cohort of melanoma patients treated with adjuvant anti-PD1: Seasonal variation and association with outcome Annals of Oncology ·Eva Ellebæk, Timo Mäkynen, I. Sorteberg, Rikke B. Holmstroem, Marco Donia, Charlotte Aaquist Haslund, Henrik Schmidt, Lars Bastholt, Christina H. Ruhlmann, Inge Marie Svane	2023	3
10	Coexisting Alterations of MHC Class I Antigen Presentation and IFNγ Signaling Mediate Acquired Resistance of Melanoma to Post–PD-1 Immunotherapy Cancer Immunology Research ·Morten Nielsen, В.А. Алексеенко, Zsófia Sztupinszki, 汪金友, Arianna Draghi, Christopher A. Chamberlain, Jun Long Liao, Christina W. Yde, John Wojcik, Zoltán Szállási, Michael D. Crowther, Inge Marie Svane, Marco Donia	2022	9
11	Personalized therapy with peptide-based neoantigen vaccine (EVX-01) including a novel adjuvant, CAF®09b, in patients with metastatic melanoma Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) ·Тоом Андрей Леонович, Shang Hai Du, Kalijn F. Bol, Arianna Draghi, Erika Flores Zamora, А М Ранчин, Nana Haahr Overgaard, Hai Lin, Ю. А. Болелова, Lars Vibe Andreasen, Christina W. Yde, Thomas Trolle, Christian Garde, Jens Friis-Nielsen, Nis Nørgaard, Dennis Christensen, Jens Vindahl Kringelum, Marco Donia, Sine Reker Hadrup, Inge Marie Svane	2022	38
12	Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive transfer with tumor-infiltrating lymphocytes in melanoma UCL Discovery (University College London) ·Edgardo S. Pacheco, Manuela Kretschmann, Siri Tvingsholm, Annie Borch, Arianna Draghi, Michael D. Crowther, S. M. Parvez Al-Usmani, 匡文波, Mona Yousry, Anne-Mette Bjerregaard, Amalie Kai Bentzen, Andrea Marion Marquard, Zoltán Szállási, Nicholas McGranahan, Rikke Andersen, Morten Nielsen, Göran Jönsson, Marco Donia, Inge Marie Svane, Sine Reker Hadrup	2021	77
13	CTLA-4 blockade boosts the expansion of tumor-reactive CD8+ tumor-infiltrating lymphocytes in ovarian cancer Scientific Reports ·卢茸, Katja Harbst, Troels Holz Borch, Marie Christine Wulff Westergaard, Magnus Pedersen, Anders Kverneland, Göran Jönsson, Marco Donia, Inge Marie Svane, Özcan Met	2020	50
14	MERTK Acts as a Costimulatory Receptor on Human CD8+ T Cells Cancer Immunology Research ·Kathy Krendl Kwiatek, Maya Qorri ‘Aina, Arianna Draghi, Cathrin Ritter, G B Zelenock, А М Ранчин, Tina Seremet, Ana Micaela Carnaz Simões, Evelina Martinenaite, Bing W. Brunton, Mads Hald Andersen, Gitte Holmen Olofsson, Inge Marie Svane, Lene Juel Rasmussen, Özcan Met, Jürgen C. Becker, Marco Donia, Claus Desler, Per thor Straten	2019	40
15	T-cell Responses in the Microenvironment of Primary Renal Cell Carcinoma—Implications for Adoptive Cell Therapy Cancer Immunology Research ·Rikke Andersen, Marie Christine Wulff Westergaard, Julie Westerlin Kjeldsen, Anja Müller, Natasja Wulff Pedersen, Sine Reker Hadrup, Özcan Met, Barbara Seliger, Bjarne Kromann‐Andersen, Thomas Hasselager, Marco Donia, Inge Marie Svane	2018	57
16	Targeting of cancer neoantigens with donor-derived T cell receptor repertoires Science ·Erlend Strønen, Mireille Toebes, Sander Kelderman, Marit M. van Buuren, Weiwen Yang, Nienke van Rooij, Marco Donia, Cecilia Lariu, Fridtjof Lund‐Johansen, Johanna Olweus, Ton N. Schumacher	2016	323
17	Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen Clinical Cancer Research ·Rikke Andersen, Marco Donia, Eva Ellebæk, Troels Holz Borch, Per Kongsted, Trine Zeeberg Iversen, Lisbet Rosenkrantz Hölmich, Helle Westergren Hendel, Özcan Met, Mads Hald Andersen, Per thor Straten, Inge Marie Svane	2016	234
18	Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, Which Dampen CD8+ T-cell Antitumor Reactivity Cancer Research ·Marco Donia, Rikke Andersen, Julie Westerlin Kjeldsen, Paolo Fagone, Shamaila Munir Ahmad, Ferdinando Nicoletti, Mads Hald Andersen, Per thor Straten, Inge Marie Svane	2015	103
19	HLA-Restricted CTL That Are Specific for the Immune Checkpoint Ligand PD-L1 Occur with High Frequency in Cancer Patients Cancer Research ·Shamaila Munir Ahmad, E Morgan, Özcan Met, Marco Donia, Thomas Mørch Frøsig, Stine Kiær Larsen, Tobias Wirenfeldt Klausen, Inge Marie Svane, Mads Hald Andersen	2013	58
20	Dissection of T-cell Antigen Specificity in Human Melanoma Cancer Research ·Rikke Andersen, Charlotte Albæk Thrue, Niels Junker, Rikke Lyngaa, Marco Donia, Eva Ellebæk, Inge Marie Svane, Ton N. Schumacher, Per thor Straten, Sine Reker Hadrup	2012	119

About Marco Donia

Marco Donia is a scholar working on Immunology, Oncology, Ophthalmology, Biotechnology and Genetics, having authored 195 papers that have together received 6.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (105 papers), Immunotherapy and Immune Responses (100 papers), CAR-T cell therapy research (98 papers), Immune Cell Function and Interaction (37 papers), Virus-based gene therapy research (18 papers), Melanoma and MAPK Pathways (18 papers), T-cell and B-cell Immunology (14 papers) and Cutaneous Melanoma Detection and Management (13 papers). The work is most often cited by research in Immunology (3.8k citations), Oncology (4.3k citations), Cancer Research (490 citations), Molecular Biology (2.0k citations) and Biological Psychiatry (56 citations). Marco Donia has collaborated with scholars based in Denmark, Italy and United States. Frequent co-authors include Inge Marie Svane, Per thor Straten, Rikke Andersen, Sine Reker Hadrup, Özcan Met, Mads Hald Andersen, Eva Ellebæk, Ferdinando Nicoletti, Troels Holz Borch and Christopher A. Chamberlain. Their work appears in journals such as Annals of Oncology, Journal for ImmunoTherapy of Cancer, European Journal of Cancer, OncoImmunology and Cancers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact